JIBTV


Open Access Short report

CD40mAb adjuvant induces a rapid antibody response that may be beneficial in post-exposure prophylaxis

Vijay NS Bhagawati-Prasad1, Evy De Leenheer1, Nadine P Keefe1, Lorna A Ryan1, Jennifer Carlring1 and Andrew W Heath1,2*

Author Affiliations

1 Department of Infection and Immunity, University of Sheffield Medical School, Beech Hill Rd, Sheffield S10 2RX, UK

2 Adjuvantix Ltd, c/o Fusion plc, Sheffield Bioincubator, Leavygreave Rd, Sheffield, UK

For all author emails, please log on.

Journal of Immune Based Therapies and Vaccines 2010, 8:1 doi:10.1186/1476-8518-8-1

Published: 4 February 2010

Abstract

Active vaccination can be effective as a post-exposure prophylaxis, but the rapidity of the immune response induced, relative to the incubation time of the pathogen, is critical. We show here that CD40mAb conjugated to antigen induces a more rapid specific antibody response than currently used immunological adjuvants, alum and monophosphoryl lipid A™.